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Aims: Chronic pain is increasingly considered to be an international public health issue – but 
gender differences in chronic pain in Europe are under-examined. This work aimed to examine 
gender inequalities in pain across Europe.  
Methods: Data for 27,552 men and women aged 25-74 years in 19 European countries were 
taken from the social determinants of health module of the European Social Survey (2014). 
Inequalities in reporting pain were measured by means of adjusted rate differences (ARD) and 
relative adjusted rate risks (ARR).  
Results: At the pooled pan-European level, a greater proportion of women (62.3%) reported 
pain than men (55.5%) (ARD 5.5% [95% CI 4.1%, 6.9%], ARR 1.10 [95% CI 1.08, 1.13]). 
These inequalities were greatest for back/neck pain (ARD 5.8% [95% CI 4.4%, 7.1%], ARR 
1.15 [95% CI 1.12, 1.19]), but were also significant for hand/arm pain (ARD 4.6% [95% CI 
3.5%, 5.7%], ARR 1.24 [95% CI 1.17, 1.30]), and foot/leg pain (ARD 2.6% [95% CI 1.5%, 
3.8%], ARR 1.12 [95% CI 1.07, 1.18]). There was considerable cross‐national variation in 
gender pain inequalities across European countries. 
Conclusions: Significant gender pain inequalities exist across Europe whereby women 
experience more pain than men; this was most pronounced for back/neck pain. The extent of 
the gender pain gap varies by country. The gender pain gap is a public health concern, and 
should be considered in future prevention and management strategies.    
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“Women get sicker, but men die quicker” is a term used to describe gender inequalities in 
health, whereby women tend to have a higher life expectancy than men, although they live 
more of those years with morbidity.[1] In 2017, estimated life expectancies for people living 
in Europe were 83.5 years for women and 78.3 years for men, representing a gender gap of 5.2 
years.[2] This “gender paradox” is something that has been widely researched – with studies 
showing stark gender inequalities across various health outcomes and disease burden.[3,4] The 
reasons for this are complex, but it is thought that both sex (biological factors) and gender 
(social factors) play important – and interacting – roles. For example, increased incidence of 
osteoprosis in women can be largely explained by reduced levels of oestrogen associated with 
the menopause, while higher levels of depression amongst women are thought to have a genetic 
influence, as well as a social one (e.g. insecure life circumstances, feeling as though not in 
control, domestic and sexual violence).[5] Social epidemiology has attributed some of 
women’s morbidity disadvantage – and men’s mortality disadvantage – to the restraints placed 
on women’s access to social and employment-related privileges and economic resources.[6-8] 
There is a lack of research examining gender inequalities in pain at a country level – especially 
across different European countries.  
Chronic pain is something that is receiving increasing international interest from the public 
health community – not least due to the opioid epidemic. Chronic pain, defined as pain that 
persists for more than 3 months, is a global problem, and has significant impact on patients, 
their families, employers, health services and the wider economy. In the US, for example, 
chronic pain is estimated to cost over 500 billion dollars annually – a cost exceeding the annual 
costs of heart disease, cancer and diabetes.[9] Similar challenges related to chronic pain have 
also been reported across Europe – where the most recent estimates suggest that up to 40% of 
 
 
the European population experience chronic back pain.[10]  Recent estimates suggest that, in 
Denmark, for example, one million working days are lost each year due to chronic pain.[11] 
The aetiology of chronic pain is complex, and is thought to be influenced by a range of 
biological, social and behavioural factors. It is this complexity that makes chronic pain 
challenging to manage effectively, with many treatment strategies often relying on the use of 
opioid analgesics. At present, however, there are very few studies to support the long-term use 
of opioid analgesics in chronic pain management; opioids also cause adverse effects, including 
sleep disturbances, endocrine disorders, reduced immune function and increased pain through 
opioid-induced hyperalgesia. Indeed, the challenges of prescribing opioid analgesics in chronic 
pain have been well described by the US “opioid epidemic”, which has reported increasing 
levels of opioid misuse and overdose-related mortalities. The trend of increased prescribing of 
opioid analgesics in chronic pain management has also been reported across Europe.[12,13] 
Given this complexity, like other diseases, there is potential for gender differences in chronic 
pain prevalence, owing to different biological, social and behavioural factors. It is important to 
acknowledge and understand these potential differences so that appropriate treatment strategies 
can be developed, especially considering coping strategies and health-seeking behaviours may 
differ between men and women.[14,15] 
Given that the majority of the chronic pain epidemiology literature relates to the US situation, 
it is important for studies to explore chronic pain prevalence – and the associated inequalities 
– in other countries with different healthcare and welfare systems.  An extensive European pain 
survey was published in 2006 by Breivik and colleagues [16], but the major focus of this work 
was on overall pain prevalence, rather than examining any gender inequalities in pain and how 
they might vary in different European countries. We have previously reported pain prevalence 
across Europe, as well as socioeconomic inequalities in pain [10]; however, this is the first 









This study was based on cross-sectional data concerning self-reported conditions from the 
‘Social Inequalities in Health and their Determinants’ rotating module, which was included in 
the seventh round of the European Social Survey (ESS), 2014.[17,18] The ESS is a cross-
national survey conducted across Europe biennially that maps and illustrates interactions 
between institutional changes and social attitudes, beliefs and behaviour patterns. Data was 
obtained by presenting participants with a card listing several health problems e.g. muscular or 
joint pain in the back/neck, and were asked the following: “Which of the health problems on 
this card have you had or experienced in the last 12 months?” Specifically, for the pain 
variables, survey participants could choose back/neck pain, arm/hand pain or foot/leg pain. 
The health module used consisted of 40,185 respondents from 21 countries: Austria, Belgium, 
Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Ireland, Israel, 
Lithuania, Netherlands, Norway, Poland, Portugal, Slovenia, Spain, Sweden, Switzerland and 
the UK. The average response rate for all countries was 51.6%; Lithuania had the highest 
response rate with 68.9%, whereas Germany had the lowest with 31.4%. Data analysis was 
restricted to respondents aged 25-74 years to reflect “working age”. To ensure that the age 
exclusions did not impact on overall pain levels in the study population, we did a sensitivity 
 
 
analysis at the pan-European level comparing all ages (15+ years) to respondents aged 25-74 
years (Supplementary Table 1).   
Data concerning participants that did not have their gender or response to pain questions 
recorded were omitted from the analysis. Estonian responses were excluded from our analysis, 
as there was insufficient data relating to pain conditions reported. We also excluded Israel from 
our analysis, as it is not situated in Europe geographically, in line with previous work of 
Graham and colleagues.[19] After applying the above restrictions for in-eligible individuals 
and excluding cases for missing  data (n =383), our dataset included 27,552 participants 
(Supplementary Table 2). 
 
Variables 
Data was analysed for three forms of pain: back/neck pain, arm/hand pain and foot/leg pain. 
We amalgamated results from these three pain variables and created a dichotomous variable to 
signify if participants had experienced at least one of the three forms of pain. RStudio (R 
v.3.5.1) was used to appropriately weight different populations and obtain pain prevalence 
estimates. Prevalence estimates were calculated for the pooled dataset and across all 19 
European countries for which we had data.   
 
Analysis 
Inequalities in reporting pain were measured by means of adjusted rate differences (ARD) and 
relative adjusted rate risks (ARR). Age-controlled ARDs and ARRs were calculated from 
predicted probabilities generated by means of binary logistic regression for pooled European 
data and country specific analysis. The ARD and ARR both express the relationship between 
 
 
two predicted probabilities based on observations and an estimated model. Stata 15.1 was used 
to conduct analyses concerning inequalities (obtaining ARD and ARR values); pain gender 
inequality was defined where both ARD and ARR were significantly different.  
The ARD represents an absolute risk measure (absolute gender pain inequality/gap), and 
estimated whether the absolute difference is statistically different to zero. ARRs are calculated 
from predicted probabilities (the ratio of two probabilities); it compares the risk of a variable 
being present (taking place) when another variable (exposure) is present (relative gender pain 
inequality/gap). Here, we assessed the risk of pain among women in comparison to the risk of 
pain among men (reference group). An ARR value of >1 indicated higher risk among women, 
whereas <1 indicated lower risk among women. Data pertaining to ARDs and ARRs were input 
into Arc Map (v.10.5) in a CSV format. Data pertaining to ARDs and ARRs were input into 
Arc Map (v.10.5) in a CSV format. Shape-files sourced from the Nomenclature of Territorial 
units for Statistics (NUTS) were attached to attribute data to produce choropleth maps using 
ten equal interval categories. 
Weights 
Age was controlled with reference to ten age groups that consisted of 5-year intervals. These 
age intervals were weighted in accordance with the European Standard Population (ESP).[20] 
To calculate pooled weights, the population size weight (pweight) which corrects for different 
population sizes between countries was combined with the post-stratification weight 
(pspweight) which uses information on age-group, gender, education and region to reduce the 
sampling error and potential non-response bias of the survey. For country-specific estimates, 






Our findings show that a notable percentage of men and women across Europe experience pain.  
The prevalence of pain varied largely between different countries, as did the degree of gender 
inequality in pain. Overall, a greater proportion of women (62.3%) reported pain than men 
(55.5%), which was observed across all three-pain variables: the most common location was 
back/neck pain, experienced by 47.3% of women and 40.8% men. Then foot/leg pain, 
experienced by 26.6% of women, and 24.3% of men, while 27.4% of women and 22.8% for 
men experienced hand/arm pain (Table 1). 
At a pan Europe level, when examining all pain variables, gender pain inequalities were seen 
in both absolute and relative terms – with women more likely to report pain (ARD 5.5% [95% 
CI 4.1%, 6.9%], and ARR 1.10 [95% CI 1.08, 1.13]) (Table 2, and visually in Figure 1). These 
inequalities were greatest for back/neck pain (ARD 5.8% [95% CI 4.4%, 7.1%] and (ARR 1.15 
[95% CI 1.12, 1.19]), but were also significant for hand/arm pain (ARD 4.6% [95% CI 3.5%, 
5.7%] and ARR 1.24 [95% CI 1.17, 1.30]), and foot/leg pain (ARD 2.6% [95% CI 1.5%, 3.8%] 
and ARR 1.12 [95% CI 1.07, 1.18]).  
 
Country level 
At an individual country level for the pooled pain variables, a gender pain gap was observed in 
most countries – with 9 countries showing significant gender inequalities for total pain (for 
which we define as a significant difference in ARD and ARR). The gender pain gap was 
greatest in Slovenia (ARD 12.4% [95% CI 5.3%, 19.4%] and ARR 1.25 [95% CI 1.09, 1.42]) 
according to absolute measures. According to relative measures, however, the gender pain was 
 
 
greatest in the Czech Republic (ARD 8.8% [95% CI 3.7%, 13.8%], and ARR 1.29 [95% CI 
1.11, 1.49]). Overall, for the pooled analysis, there were no significant gender pain inequalities 
in relative or absolute measures reported in Denmark, Austria, Belgium, Switzerland, United 
Kingdom, Poland, Hungary and Portugal. 
In terms of inequalities for each pain variable, there were significant gender pain inequalities 
observed in 11 countries for back/neck pain; Spain had the highest gender pain inequalities in 
both relative and absolute terms (ARD 12.7% [95% CI 7.4%, 18.1%]) and ARR 1.36 [95% CI 
1.19, 1.55]), followed by Finland in absolute terms (ARD 11.3% [95% CI 5.7%, 16.9%]) and 
ARR 1.23 [95% CI 1.11, 1.37]), and Czech Republic in relative terms (ARD 7.4% [95% 2.7%, 
12.1%] and ARR 1.35 [95% CI 1.11, 1.64]). No significant gender pain inequalities in relative 
or absolute measures were reported for Denmark, Austria, Belgium, Ireland, United Kingdom, 
Lithuania, Hungary, and Portugal. 
For hand/arm pain, significant gender pain inequalities were observed in 6 countries, with 
Portugal showing the highest pain gap in both relative and absolute terms (ARD 20.6% [95% 
CI 12.9%, 28.3%], and ARR 1.85 [95% CI 1.44, 2.38]), followed by Spain (ARD 12.5% [95% 
CI 7.8%, 17.2%]) and ARR 1.61 [95% CI 1.34, 1.94]). No significant gender pain inequalities 
in relative or absolute measures were reported for Denmark, Finland, Austria, Switzerland, 
France, Ireland, Netherlands, United Kingdom, Poland, Slovenia, Lithuania, and Hungary. 
For foot/leg pain, significant gender pain inequalities were observed in 5 countries; Norway 
had the highest inequalities using absolute measures (ARD 11.3% [95% CI 5.5%, 17.1%] and 
ARR 1.50 [95% CI 1.22, 1.84]), while Czech Republic had the highest inequalities using 
relative measures (ARD 5.9% [95% CI 2.1%, 9.6%] and ARR 1.58 [95% CI 1.17, 2.12)]. No 
significant pain inequalities in relative or absolute measures were reported for Finland, Austria, 
 
 
Belgium, Switzerland, Germany, France, Ireland, Netherlands, United Kingdom, Poland, 
Slovenia, Lithuania, and Hungary.  
Discussion 
This paper used data from the seventh wave of the ESS from 2014 to establish the extent of 
gender pain inequality in 19 European countries. We have identified several key findings that 
may be important for researchers, practitioners, and policy makers. Firstly, at the pan-European 
level, there are significant gender pain inequalities with women more likely to experience pain 
than men, across all the three pain variables.  Secondly, gender pain inequalities were more 
common for back/neck pain, with 11 out of 19 European countries showing significant 
inequalities, compared to hand/arm pain and foot/leg pain where only 6 and 5 countries 
respectively showed significant gender pain inequalities. Thirdly, the magnitude of the gender 
pain inequalities differed between European countries – with some countries exhibiting no 
gender pain divides. 
Our work adds to the international literature on gender and health that shows that women 
experience more morbidity than men. Research has found that although life expectancy is lower 
for men, women’s advantage does not translate into healthier years.[21] Women steadily report 
worse health status than men and suffer from a higher burden of non-fatal and debilitating 
conditions, such as arthritis, depression, pain, or mobility problems.[22] Our research supports 
this by demonstrating significant gender inequalities in pain. Further, our work substantially 
extends the emerging international literature on the epidemiology of pain and inequalities in 
pain.[10,23] Previous research has similarly found that the prevalence of pain is higher in 
women – our work shows this is also the case in Europe.[24-26] Previous work using the ESS 
has reported on socioeconomic inequalities in pain prevalence across Europe, and showed that 
the inequalities were most pronounced for hand/arm pain, and least pronounced for back/neck 
 
 
pain.[10] These findings are in partial agreement to our work where we report gender pain 
inequalities were most pronounced in hand/arm pain and least pronounced in foot/leg pain. 
Research has also found that women have higher rates of severely and moderately limiting pain 
as well as greater pain intensity.[23] 
The reasons for these gender inequalities are complex, and not completely understood, 
although there appears to be a biological basis that helps to account for these gender 
differences; for example, sex hormones, such as oestrogen, can influence pain sensitivity.[27] 
Similarly, among different animal models, it has been shown that female rodents are more 
sensitive to chemical, heat and electrical signals than males.[28-30] Animal models have also 
shown that females have lower levels of stress-induced analgesia compared to males. Although 
these biological differences are well characterised, they do not fully explain our findings, given 
it is likely that pain sensitivity is also mediated by social and economic factors. Indeed, social 
epidemiological research has found that national and cross-national social policies 
implemented to support women and to promote gender equality (e.g. increasing gender equality 
in access to jobs, income, use of time, division of care work and political representation) are 
associated with improved health outcomes for women or decreased gender health 
inequalities.[31-33] This may also be the case for chronic pain – and is something that future 
research could examine.  
Our work also has important public health policy and health care practice implications: pain 
and gender inequalities in pain are not a marginal issue, and should be acknowledged in any 
pain treatment strategies going forward especially as increased pain is associated with higher 
opioid use.[23] Women are therefore potentially more at risk from the multiple side effects of 
opioid treatments (which include sleep disturbances, endocrine disorders, reduced immune 
function and increased pain through opioid-induced hyperalgesia). Whilst little can be done 
about the biological factors associated with higher pain prevalence (e.g. hormone levels), there 
 
 
is potential to change social circumstances in order to reduce the gender pain gap and to provide 
additional support/tailor treatments to women. Given the magnitude of the gender pain 
inequalities was highly variable between European countries, there may be opportunities to 
reduce these inequalities through health care or other measures. Future work could explore this 
further.  
This study provides a unique insight into gender pain inequalities at a pan-European level using 
a comparative and robust dataset.  However, our work should be considered in view of several 
limitations, as described below. For a detailed discussion regarding the strengths and 
limitations of the ESS data, see the work by Eikemo and colleagues.[17] Regarding our choice 
of model, we acknowledge that the use of logistic regression models has limitations for 
comparing outcome across groups due to the unobserved differences between groups. We 
intended to examine the inequality in pain prevalence between male and females, across 
European countries and Linear Probability model (LPM) are also suitable for this purpose.[34] 
To ensure our methodology was appropriate, we estimated the coefficients from the LPM 
across 19 European countries and Europe overall. We then compared these data with findings 
from binary logistic regression, which showed results of the logistic regression and LPM were 
in broad agreement (Supplementary Table 3). 
Further a further limitation is that pain measures included in the survey were self-reported; as 
such, it was the sole responsibility of the participant to correctly identify if they experienced 
pain in the last 12 months, participant responses were not verified using medical records. 
Although we do accept that people who experience pain may not necessarily seek medical 
treatment, meaning that not all types of pain will be able to be verified from medical records. 
Further, we did not explore the intensity, severity, or type of pain in the survey so we did not 
consider this in our analysis. It is also possible that people might respond to the questions on 
pain differently (e.g. people with different cultural backgrounds). Caution is also recommended 
 
 
when translating pain estimates produced by our work into statements concerning the wider 
population, as our data was obtained using a survey as opposed to examining registry data. 
Whilst precaution was taken to avoid bias through the use of weightings, the survey selection 
technique may have resulted in a non-representative sample, as those with severe health 
conditions may have been unable to partake in the survey. As well as that, the ESS only samples 
from the non-institutionalised population thus potentially leading to bias, given the 
institutionalised population are more likely to be affected by poor health. We also note that 
response rates varied from country to country: while the ESS sets out 70% response rate targets, 
there were several countries that did not reach this target, although it is worth noting that this 
is not a direct indicator of a poor-quality dataset. Although the ESS collects data from 19 
European countries covering all regions, there were several European countries not covered in 
the survey. Thus, our findings cannot be generalised to all European countries. Finally, the 
primary focus of our work aimed to establish if there were gender inequalities in pain 
prevalence across European countries; we did not seek to explain or account for these 
inequalities in our analysis. Future work should be more explanatory in nature and seek to 




This study provides the first comprehensive overview of gender pain inequalities across 
Europe. The most common type of pain experienced by both men and women was back/neck 
pain. At the pan-European level, significant gender pain inequalities exist whereby women 
experience more pain than men; this was most pronounced for back/neck pain. While this was 
found at a pan-European level, the extent of the gender pain inequality varied by country, as 
 
 
different degrees of inequality in pain were reported by different countries. This gender pain 
divide is a public health concern, and it should be considered in any future pain prevention and 
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Table and Figure Legends 
 
 
Table 1: Prevalence of pain by gender in 19 European Countries. 
Table 2: Age-adjusted rate differences (ARD) and age-adjusted rate ratios (ARR) for gender 
inequalities in back/neck pain, hand/arm pain, and foot/leg pain in 19 European Countries. Pain 
in men was the reference group. ARD estimated whether absolute difference is statistically 
different to 0, while ARR assessed if the rate ratio is significantly different to 1 (where 1 is 
equal risk).  Pain inequality was defined where the ARD and ARR were both statistically 
significant. 
Figure 1: A map illustrating age‐adjusted rate differences (ARDs) and age-adjusted risk ratios 
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% (Overall)  
Europe (pooled)  Men 40.8 22.8 24.3 55.5 
   Women 47.3 27.4 26.6 62.3 
North Denmark Men 49.5 25 24.1 65.6 
    Women 52.1 29.9 33.3 66.4 
  Finland Men 48.6 24.9 30.4 66.1 
    Women 58.6 25.6 32.9 75.7 
  Norway Men 40.0 19.5 22.5 58.4 
    Women 47.5 31.2 31.5 65.4 
  Sweden Men 43.0 24.1 24.6 60.1 





Men 32.2 14.1 17.3 44.0 
Women 36.5 16.2 13.8 45.3 
Belgium 
Men 50.0 25.3 25.1 65.0 
Women 55.7 31.0 29.0 69.7 
Switzerland 
  
Men 37.8 17.3 24.4 54.4 
Women 43.6 20.8 20.7 58.0 
Germany 
  
Men 48.6 21.5 24.8 62.1 
Women 59.6 26.3 27.7 70.5 
France 
  
Men 46.6 28.7 28.1 62.2 
Women 54.9 35.0 26.2 73.1 
Ireland 
  
Men 20.0 9.2 12.6 31.0 
Women 24.3 12.4 13.8 34.6 
Netherlands 
  
Men 37.3 20.0 20.1 53.8 




Men 38.8 22.7 26.9 56.4 
Women 39.1 24.0 27.5 57.9 
Central/Eastern Poland Men 30.7 23.0 22.0 47.3 
    Women 38.2 25.6 22.2 53.9 
  Slovenia Men 38.1 22.0 17.2 49.6 
    Women 46.7 21.2 22.5 49.6 
  Lithuania Men 25.9 9.9 11.9 34.0 
    Women 27.4 11.2 13.9 37.6 
  Czech Republic Men 21.3 9.5 10.6 31.1 
    Women 29.1 14.7 16.7 40.0 
 
Hungary 
Men 16.5 11.6 14.9 25.2 
 Women 17.2 14.5 17.3 28.7 
South Portugal Men 44.0 22.0 27.3 59.3 
    Women 50.7 40.2 36.6 68.4 
  Spain Men 33.9 20.2 21.3 50.6 
    Women 48.9 33.1 30.9 64.4 
 
Table 1: Prevalence of pain by gender in 19 European Countries.  
Note: Prevalence's were weighted using ESS post‐stratification weights and adjusted to the standard European 
population in accordance with the European Standard population (ESP) of 2013. Source: European Social 
Survey (2014). 
 


















 Europe 19 countries 5.8  






































































































































































































Table 2: Age-adjusted rate differences (ARD) and age-adjusted rate ratios (ARR) for gender inequalities in back/neck pain, hand/arm pain, and foot/leg pain in 19 European 
Countries. Pain in men was the reference group. ARD estimated whether absolute difference is statistically different to 0, while ARR assessed if the rate ratio is significantly 































































































































South Spain 12.7% 
(7.4%, 18.1%) 
1.36 
(1.19, 1.55) 
 
12.5% 
(7.8%, 17.2%) 
1.61 
(1.34, 1.94) 
8.3% 
(3.6%, 13.0%) 
1.38 
(1.15, 1.66) 
11.2% 
(5.8%, 16.5%) 
1.22 
(1.10, 1.34) 
Portugal -0.4% 
(-9.0%, 8.3%) 
0.99 
(0.83, 1.18) 
 
20.6% 
(12.9%, 28.3%) 
1.85 
(1.44, 2.38) 
10.5% 
(2.8%, 18.2%) 
1.37 
(1.08, 1.74) 
4.1%  
(-4.0%, 12.2%) 
1.06 
(0.94, 1.20) 
